• 대한한방부인과학회지
• /
• 제21권3호
• /
• pp.111-120
• /
• 2008

Purpose: Although premsnstrual syndromes(PMS) have long been recognized, there has been difficulty to evaluate the symtoms. Usually the questionnaire has been used to dignose the PMS. Objective is to investigate the relationship of body temperature between women with PMS and without PMS. Methods: We studied 23 patients visiting ㅇㅇ hospital from 26th December 2005 to 26th April 2006. The Questionnaire for PMS was used to evaluate physical, emotional, and behavioral symptoms accompanying the menstrual cycle of the subjects. The subjects were categorized in two groups, non-PMS(11) and PMS group(12). Body temperature was assessed by Dorex spectrum 9000MB (DOREX Inc.. USA). We measured CV4, CV3, CV12 and CV17 to evaluate the distribution of body temperature, compared the difference of temperature(${\Delta}T$) between CV17-CV4, CV17-CV3, CV17-CV12 and CV12-CV3. We investigated the of temperature and ${\Delta}T$ between two groups by Mann-Whitney U-test. Results: The temperature of CV3 and CV 4 of PMS located in low abdomen were lower than those of non-PMS located in chest. But there was no statistical significance of temperature between two groups. There was lower temperature of low abdomen in PMS group than non-PMS group without statistical significance. Conclusion: The results suggest that DITI could be useful to assess the PMS objectively. But more research should be needed.

• 대한한방부인과학회지
• /
• 제35권4호
• /
• pp.77-90
• /
• 2022

Objectives: This study was aimed to figure out korean medicine doctors' opinion and treatment of Korean medicine clinical practice guidelines (CPG) for premenstrual syndrome (PMS). Methods: We conducted a questionnaire survey targeting korean medicine doctors belonging to the Korean Association of Oriental Medicine by e-mail and text and analyzed the answers. Results: 1. The average monthly number of patients visiting the respondents' clinics for PMS was 2.7, the main age group was 20-30s (80.8%) and the treatments the patients given before were mostly western treatments such as painkiller and combined oral contraceptives. 2. The treatment period for PMS was mostly less than 3 months (69%), and the frequency of acupuncture treatment was the most twice per week (41.1%). 3. The most effective herbal medicine for affective symptoms was Soyo-san, and for physical symptoms was Gyejibokryung-hwan. The most commonly used acupuncture point was 三陰交 (SP6). 4. Other opinions of the clinicians about Korean medicine clinical practice guideline of PMS were the need for promotion of PMS, convenience of taking herbal medicines and price competitiveness. Conclusions: We figured out korean medicine doctors' opinion of PMS CPG, clinical diagnosis and treatment.

• 대한한방부인과학회지
• /
• 제36권3호
• /
• pp.154-172
• /
• 2023

Objectives: This study aimed to assess the clinical evidence supporting the use of acupuncture (AC) for premenstrual syndrome (PMS). Methods: We searched randomized controlled trials (RCTs) that used AC for PMS in 9 databases (PubMed, EMBASE, Cochrane Library, CINAHL, CNKI, CiNii, SCIENCE ON, KoreaMed, OASIS) from their inception to July 2022. Results: We identified 1,168 studies, of which 15 RCTs met the inclusion criteria. The risk of bias in the included studies was relatively unclear or high. Meta-analysis of 3 RCTs showed that the AC group had a significantly higher effective rate than the Medroxyprogesterone group (RR 1.48, 95% CI (1.23, 1.78), p<0.0001). Meta-analysis of 2 RCTs showed that there was no statistically significant difference between the AC group and the Sham AC group in the effective rate (RR 4.72, 95% CI (0.88, 25.36), p=0.07). In a review of individual studies, the AC group was more effective than the control group in terms of the effective rate, symptom scale, quality of life, adverse events, and recurrence rate. Conclusions: The AC group was more effective than general treatments groups such as sham AC, western medicine, and dietary supplements, and there were no serious adverse events. However, the evidence on the effectiveness and safety of acupuncture for PMS was inconclusive due to the small number of included studies and low quality. Therefore, systematic reviews based on more rigorously designed randomized clinical trials are needed in the future to properly evaluate the effect of AC on PMS.

• 한국식품과학회지
• /
• 제51권2호
• /
• pp.182-187
• /
• 2019

본 연구는 슈퍼홍미 미강 추출물이 폐경 후 갱년기 증상에 및 대사 개선 효과를 확인하고자 수행되었다. 무월경이 지속된 지 5년 미만의 여성을 대상으로 12주동안 진행되었으며 위약대조군 15명, 실험군 15명으로 배정하였고, 1일 2개의 캡슐을 섭취하도록 하였다(슈퍼홍미 미강추출물 700 mg/day). 시험 종료 후 슈퍼홍미 미강 추출물 섭취군의 체중과 BMI 그리고 중성지질과 및 총콜레스테롤은 수준이 유의하게 감소하였다. 혈중 HDL 콜레스테롤과 ApoA1 농도는 약 10% 증가하여 지질대사 개선에 효과를 기대할 수 있었다. 항당뇨과 관련된 지표 중 혈중 glucose와 인슐린이 유의하게 감소하여 인슐린 저항성 지표인 HOMA-IR이 감소한 것을 확인할 수 있었고, 아디포넥틴 수준이 유의하게 증가하였으며, $TNF-{\alpha}$는 슈퍼홍미 미강 추출물 섭취군에서 투여 전보다 유의하게 감소하여 폐경 이후 당질대사 개선에 도움을 줄 수 있을 것으로 보인다. 항산화활성 분석 결과 SOD1, GSH 그리고 TBARS 수준이 실험군에서 감소하였으며, AOPP 는 유의적인 차이를 보이지 않았다. 여성호르몬 중 $17{\beta}-estradiol$과 progesterone 농도는 위약대조군에서 유의하게 감소하였으나 실험군은 섭취기간동안 호로몬 농도를 유지한 것으로 나타나 대조군에 비해 높은 수준을 나타났다. 폐경을 겪은 여성들은 여성호르몬 저하로 인해 갱년기 증상 및 대사증후군 발병 가능성이 증가하는데 슈퍼홍미 미강과 같은 기능성 식품 섭취로 대사증후군 위험인자들에 대한 호전이 높을 것이라 보고 이러한 연구 결과는 갱년기 여성 건강에 시사하는 바가 크다고 생각된다.

• 대한지역사회영양학회지
• /
• 제10권5호
• /
• pp.603-614
• /
• 2005

This study was performed to investigate the correlation between Premenstrual syndrome (PMS) and nutritional intake, blood composition of female students. One hundred and one female students were selected as the experimental subjects at Gyeongsang National University. To assess the PMS symptoms of the subjects, a questionnaire (PAP) score based on the methods of Halbreich, Endicor and Nee was prepared with 34 different items. Dietary survey was conducted by 24­hour recall method for 3 days and nutrient intakes were analyzed by the CAN-Pro. Blood composition of WBC, RBC, Hb, Hct, Ca and Mg was measured. The average height, weight and BMI of subjects were $160.7\pm4.6cm,\;54.1\pm5.7kg\;and\;21.2\pm1.9$, respectively. Average intakes of energy, calcium, iron, zinc, vit $B_2$, and folic acid per day were $1810.2\pm344.9kcal(90.5\%\;of\;RDA),\;621.1\;197.3mg(88.7\%\;of\;RDA),\;15.9\;pm4.9mg\;(99.3\%\;of\;RDA),\;8.1\pm3.4mg(80.5\%\;of\;RDA),\;1.1\pm0.6mg(88.3\%\;of\;RDA)\;and\;234.3\pm78.6{\mu}g(93.7\%\;of\;RDA)$, respectively. Score of the behavioral symptoms, psychologic symptoms, physical symptoms and other symptoms were recorded $1.79\pm0.86,\;2.11\pm1.08,\;2.31\pm1.11\;and\;1.58\pm0.86$, respectively. The relation between PMS and menstrual cramps was significant. A significant difference was observed for menstruation amount in physical symptoms (p<0.05) and other scores (p<0.05). The group who drinks alcohol over 30g per day showed higher scores at total PAP (p<0.05), psychologic symptoms (p<0.05), physical symptoms (p<0.05), and other scores (p<0.05) than those who don't drink alcohol. Calcium in the blood showed a negative correlation with total PAF score (p<0.05), behavioral symptoms (p<0.05), physical symptoms (p<0.05) and other scores (p<0.01). Magnesium in the blood showed a negative correlation with physical symptoms (p<0.05), other score (p<0.05). WBC was negatively associated with psychologic scores (p<0.05). Hb and Hct were negatively associated with other scores (p<0.05). In conclusion, calcium intake showed a level of $88.7\%$ of RDA and this study revealed that there is a correlation between PMS and blood composition in female college students. Therefore, calcium and magnesium supplements can be beneficial to relieve PMS symptoms.

• 대한한방부인과학회지
• /
• 제36권4호
• /
• pp.96-120
• /
• 2023

Objectives: This study reports the findings that support the efficacy of herbal medicine (HM) for premenstrual syndrome (PMS). Methods: We conducted meta-analysis of findings from randomized controlled trials (RCTs) for PMS treated with HM. The articles were published before July 2022, located using 9 databases (Pubmed, EMBASE, Cochrane Library, CINAHL, CNKI, CiNii, SCIENCE ON, KoreaMed, OASIS). Results: We observed 2,034 studies, of which 23 RCTs met our inclusion criteria. The risk of bias in the included studies was relatively unclear or high. Meta-analysis of 3 RCTs showed that HM group had a significantly higher total effective rate than the western medicine group (RR 1.20 [95% CI 1.06, 1.36, p=0.004]). Meta-analysis of 1 RCT showed that HM group had a significantly lower symptom score (MD -3.04 [95% CI -5.36, -0.72, p=0.01]), while there was no significant difference in daily record of severity of problems scale (MD -20.52 [95% CI -49.33, 8.29, p=0.16]). Conclusions: HM significantly improved PMS symptoms than general treatment and no serious adverse events were reported. However, the evidence on the effectiveness and safety of HM for PMS was not enough to provide reliable results due to the small number and low quality of included studies. We believe that rigorous RCTs will lead to more reliable evidence of the intervention.

• 감성과학
• /
• 제10권2호
• /
• pp.243-252
• /
• 2007

효모 (Saccharomyces cerevisiae)는 인체에 무해한 Generally Recognized As Safe(GRAS)급으로 인정되며, 최근 효모 추출물이 정신적 긴장, 과민, 두통 같은 월경 전 증후군을 완화시키는 효과가 있음이 보고되어 있어, 효모추출물(Saccharomyces cerevisiae extract: SCE)과 그 분획(SCE-40)이 우울증과 불안증에서도 효과가 있는지 확인하고자 다음 실험을 실시하였다. 행동학적 검정으로 SCE의 항우울 효과를 확인하기 위해 SCE를 0, 1, 10, 100mg/kg의 농도로 웅성 ICR 생쥐에게 2주간 경구 투여한 후 강제수영검사(forced swimming test; FST)에서의 부동시간과, 또 다른 항우울 효과 검정 실험인 미현수검사(Tail Suspension Test: TST)에서의 부동시간을 측정하였다. 또한, SCE의 항불안 효과 검정을 위해서 SCE를 0, 1, 10, 100mg/kg의 농도로 웅성 ICR 생쥐에게 1회(1시간 전), 혹은 2주간 경구 투여한 후 고위십자미로검사(Elevated-plus-maze test : EPM)에서의 open arms에 머문 시간을 측정하였다 시험관내 실험으로는 웅성 백서의 대뇌피질에서의 SCE 및 SCE-40의 serotonin transporter (SERT), norepinephrine transporter(NET), 그리고 GABA의 ligand의 결합 억제능 측정과, serotonin (5-hydroxytryptamine: 5-HT), norepinephrine uptake 측정이 수행되었다. 행동적 실험 결과, FST에서 1회나 2주간 SCE 10mg/kg과 100mg/kg을 투여 받은 생쥐에서 생리 식염수만 투여 받은 생쥐보다 부동시간이 유의하게 감소됨을 보여 SCE에 의해 항우울 효과가 유발됨을 보였고, TST 실험에서도 유사한 결과가 나타났다. 또한, 항불안을 측정하는 EPM 실험에서도 1회나 2주간 SCE 10mg/kg과 100mg/kg을 투여 받은 생쥐에서 생리 식염수만 투여 받은 생쥐보다 open arms에서 머무는 시간이 유의하게 증가되어 SCE가 단기 또는 장기간의 항불안에 효과가 있음을 나타냈다. 시험관내 실험 결과에서는, SCE와 SCE-40이 SERT, NET, 그리고 GABA ligand의 결합 억제능이 있음이 확인되었고, SCE와 SCE-40은 serotonin(5-hydroxytryptamine: 5-HT)과, norepinephrine의 uptake를 억제하는 것으로 나타났다. 그러므로 본 연구는 효모 추출물(SCE)과 그 분획(SCE-40)이 행동적, 신경학적으로 항우울, 항불안에 효과가 있음을 확인하였으며, 효모 추출물(SCE)과 그 분획(SCE-40)이 안전한 천연식품으로서 우울증, 불안증 등의 관련 질환의 예방, 치료용 의약품 개발과 기능성 식품에 효과적으로 이용될 수 있음을 시사한다.